학술논문
Review of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder
Document Type
Abstract
Report
Report
Author
Source
Journal of Central Nervous System Disease. August 23, 2017, p1, 11 p.
Subject
Language
English
ISSN
1179-5735
Abstract
ABSTRACT: Lisdexamfetamine dimesylate (LDX) is the first prodrug stimulant used for the treatment of attention-deficit/hyperactivity disorder (ADHD) dosed once daily. Due to its long-acting properties, LDX remains pharmacologically inactive until [...]